Additional information for medical specialists

References:

  1. Calabrese C., Gregory W.L., Leo M., Kraemer D., Bone K., Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J. Altern. Complement. Med. 2008;14:707–713. doi: 10.1089/acm.2008.0018.
  2. Devishree R.A., Kumar S., Jain A.R. Short term effect of Bacopa monnieri on memory- A brief review. J. Pharm. Res. 2017;11:1447–1450.
  3. Aguiar S., Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16:313–326. doi: 10.1089/rej.2013.1431.
  4. Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci. 2008; 73(1):R14-R19.
  5. Amieva H, Meillon C, Helmer C, Barberger-Gateau P, Dartigues JF. Ginkgo biloba extract and long-term cognitive decline: A 20-year follow-up population-based study. PLoS One. 2013; 8(1):52755.
  6. Müller WE, Eckert A, Eckert GP, Fink H, Friedland K, Gauthier S et al. Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease. World J Biol Psychiatry. 2017: 1-7.
  7. Solfrizzi V, Panza F. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract. J Alzheimers Dis. 2015; 43(2):605-611.
  8. Ossoukhova A, Owen L, Savage K, Meyer M, Ibarra A, Roller M et al. Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefolius L.) to healthy middle‐age adults. Hum Psychopharmacol Clin Exp. 2015; 30(2):108-122.
  9. Heo JH, Lee ST, Oh MJ, Park HJ, Shim JY, Chu K et al Improvement of cognitive deficit in Alzheimer’s disease patients by long term treatment with Korean red ginseng. J Ginseng Res. 2011; 35(4):457-461.
  10. Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi SH, Kang J et al. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer’s disease-related neuropathies: involvement of non-amyloidogenic processing. J Alzheimers Dis. 2012; 31(1):207-223.
  11. Kim J, Kim SH, Lee DS, Lee DJ, Kim SH, Chung S et al. Effects of fermented ginseng on memory impairment and β-amyloid reduction in Alzheimer’s disease experimental models. J Ginseng Res. 2013; 37(1):100-107.
  12. Lee MS, Yang EJ, Kim JI, Ernst E. Ginseng for cognitive function in Alzheimer’s disease: A systematic review. J Alzheimers Dis 2009;18:339–344.
  13. Jintanaporn Wattanathorn,Lugkana Mator, Supaporn Muchimapura, Terdthai Tongun, Orapin Pasuriwong, Nawanant Piyawatkul, Kwanchanok Yimtae, Bungorn Sripanidkulchai, Jintana Singkhoraard. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica, PMID: 18191355.
  14. Orhan IE. Centella asiatica (L.) Urban: from traditional medicine to modern medicine with neuroprotective potential. Evid Based Complementary Altern Med. 2012.
  15. Chen CL, Tsai WH, Chen CJ, Pan TM. Centella asiatica extract protects against amyloid b1e40-induced neurotoxicity in neuronal cells by activating the antioxidative defence system. J Tradit Complement Med. 2015:1-8.
  16. Gray NE, Harris CJ, Quinn JF, Soumyanath A. Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. J Ethnopharmacol. 2016; 180:78-86.
  17. Gray NE, Zweig JA, Murchison C, Caruso M, Matthews DG, Kawamoto C et al. Centella asiatica attenuates Aβ- induced neurodegenerative spine loss and dendritic simplification. Neuroscience Letters. 2017; 646:24-29.
  18. Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med. 2017; 7(4):433-440.
  19. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomized and placebo‐controlled trial. J Clin Pharm Ther. 2003; 28(1):53-59.
  20. Miroddi M, Navarra M, Quattropani MC, Calapai F, Gangemi S, Calapai G et al. Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer’s disease. CNS Neurosci Ther. 2014; 20(6):485-495.
  21. Sallam A, Mira A, Ashour A, Shimizu K. Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis. Phytomedicine. 2016; 23(10):1005- 1011.
  22. Scholey AB, Tildesley NT, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology 2008;198:127–139.
  23. Xue W, Hu JF, Yuan YH, Sun JD, Li BY, Zhang DM, Li CJ, Chen NH. 2009. Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory. Acta Pharmacol Sin. 30:1211–1219.
  24. Wu TY, Chen CP, Jinn TR. 2011. Traditional Chinese medicines and Alzheimer’s disease. Taiwan J Obstet Gyne. 50:131–135.
  25. Chen YJ, Huang XB, Chen WQ, Wang Q. 2012a. Experimental study of tenuigenin regulating phosphorylation of Tau protein. Tianjin J Trad Chinese Med. 19:45–47.
  26. Cheong MH, Lee SR, Yoo HS, Jeong JW, Kim GY, Kim WJ, Jung IC, Choi YH. 2011. Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-kappaB activation in lipopolysaccharide-induced BV2 microglial cells. J Ethnopharmacol. 137:1402–1408.
  27. Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: A Rasayana (rejuvenator) of ayurveda. Afr J Tradit Complement Altern Med. 2011;8(Suppl 5):S208–13.
  28. Karnick CR. A double-blind, placebo-controlled clinical studies on the effects of Withania somnifera and Panax Ginseng Extracts on psychomotor performance in healthy Indian volunteers. Indian Med. 1991;3:1–5.
  29. Dhuley J. Nootropic-like effect of ashwaganda (Withania somnifera L.) in mice. Phytother Res. 2002;15:524–8.
  30. Buchwald-Werner S, Vazquez I. Effects of a Melissa officinalis special extract on mood and cognitive function. Planta Med. 2015; 81(16):SL5C_01.
  31. Miraj S, Azizi N, Kiani S. A review of chemical components and pharmacological effects of Melissa officinalis L. Pharm Lett. 2016; 8(6):229-237.
  32. Martins EN, Pessano NT, Leal L, Roos DH, Folmer V, Puntel GO et al. Protective effect of Melissa officinalis aqueous extract against Mn-induced oxidative stress in chronically exposed mice. Brain Res Bull. 2012; 87(1):74-79.
  33. Sepand MR, Soodi M, Hajimehdipoor H, Soleimani M, Sahraei E. Comparison of neuroprotective effects of Melissa officinalis total extract and its acidic and non- acidic fractions against a β-induced toxicity. Iran J Pharm Res. 2013; 12(2):415-423.
  34. Soodi M, Naghdi N, Hajimehdipoor H, Choopani S, Sahraei E. Memory-improving activity of Melissa officinalis extract in naïve and scopolamine-treated rats. Res Pharm Sci. 2014; 9(2):107-114.
  35. Pereira RP, Boligon AA, Appel AS, Fachinetto R, Ceron CS, Tanus-Santos JE et al. Chemical composition, antioxidant and anticholinesterase activity of Melissa officinalis. Ind Crops Prod. 2014; 53:34-45.
  36. Adams M, Gmu ̈ nder F, Hamburger M. Plants traditionally used in age related brain disorders – A survey of ethnobotanical literature. J Ethnopharmacol 2007;113:363–381
  37. Kennedy DO, Scholey AB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des 2006;12:4613–4623.
  38. Howes M-JR, Houghton PJ. Traditional medicine for memory enhancement. In: Ramawat KG, editor. Herbal drugs: Ethnomedicine to modern medicine. New York: Springer, 2009;239–291.
  39. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med 2008;10:259–274.
  40. Frank B, Gupta S. A review of antioxidants and Alzheimer’s disease. Ann Clin Psych 2005;17:269–286.
  41. Man SC, Durairajan SS, Kum WF, et al. Systematic review on the efficacy and safety of herbal medicines for Alzheimer’s disease. J Alzheimer Dis 2008;14:209–223.
  42. Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2006;21:113–118.
  43. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003;28:53–59.
  44. Iuvone T, De Filippis D, Esposito G, D’Amico A, Izzo AA. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-β peptide-induced neurotoxicity. J Pharmacol Exp Ther 2006;317:1143–1149.
  45. Papandreou MAA, Kanakis CDB, Polissiou MGB, Efthimiopoulos SC, Cordopatis PD, Margarity MA, Lamari FND. Inhibitory activity on amyloid-β aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 2006;54:8762–8768.
  46. Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology 2010;207:637–643.
  47. Hishikawa N, Takahashi Y, Amakusa Y, Tanno Y, Tuji Y, Niwa H et al. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012; 33(4):499-504.
  48. Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano. 2013; 8(1):76-103.
  49. Veldman ER, Jia Z, Halldin C, Svedberg MM. Amyloid binding properties of curcumin analogues in Alzheimer’s disease postmortem brain tissue. Neurosci Lett. 2016; 630:183-188.
  50. Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, et al. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease. Br J Nutr. 2016; 115(3):449-65.
  51. Schulz V. Drinking tea (Camellia sinensis) reduces the risk of dementia in old age: Epidemiological study with 2,500 participants in Singapore. Z Phytotherapie 2009;30:22–23.
  52. Maia L, De Mendonc ̧a A. Does caffeine intake protect from Alzheimer’s disease? Eur J Neurol 2002;9:377–382.
  53. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer’s disease. J Alzheimers Dis 2010;20:S117–S126.
  54. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals 2005;14:34–45.
  55. Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 2010;112:1415–1430.
  56. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: A randomized controlled trial. JAMA 2008;300:2253–2262. [Erratum in: JAMA 2008;300:2730] .
  57. Rocha-Gonza ́lez HI, Ambriz-Tututi M, Granados-Soto V. Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci Ther 2008;14:234–247.
  58. Ritchie K, Carrie`re I, De Mendonc ̧a A, et al. The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 2007;69:536–545.
  59. Hao Z, Liu M, Liu Z, Lv D. Huperzine A for vascular dementia. Cochrane Database Syst Rev 2009;2:CD007365.
  60. Wang R, Tang XC. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals 2005;14:71–82.
  61. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med 2008;10:259–274.
  62. Man SC, Durairajan SS, Kum WF, et al. Systematic review on the efficacy and safety of herbal medicines for Alzheimer’s disease. J Alzheimers Dis 2008;14:209–223.
  63. Howes M-JR, Perry NSL, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res 2003;17:1–18.
  64. Howes M-JR, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 2003;75:513–527.
  65. Lee MS, Yang EJ, Kim JI, Ernst E. Ginseng for cognitive function in Alzheimer’s disease: A systematic review. J Alzheimers Dis 2009;18:339–344.
  66. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer’s disease. J Alzheimers Dis 2010;20:S117–S126.
  67. Kennedy DO, Scholey AB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des 2006;12:4613–4623.